Thermo Fisher Scientific Inc TMO
Price alert —
Sign in to get a one-time email the moment TMO crosses your price. Free accounts included.
Sign in / create a free accountThermo Fisher Scientific Inc is a healthcare company listed in the US.
TMO last traded at $532.48, down 2.0% on the day; that's in the middle part of its 52-week range ($435.27–$643.99). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 63), the trend is strong (ADX 35), and trading is light at 0.7× normal volume. On the business side, revenue is growing 6% year over year and the business keeps about 12 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $172.45 (fair range $172–$360); today's price sits 210% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Positive retained earnings
- ✓ Gross margin 41% (pricing power)
- ⚠ Debt exceeds cash
- ⚠ Quick ratio 0.80 (fragile)
- ⚠ Inventory growing faster than revenue
Price implies ~21% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
TMO is a $196.4 billion company, priced at 29× last year's earnings.